Essay typer – FCA Cleveland http://fcacleveland.org/ Tue, 28 Jun 2022 14:22:33 +0000 en-US hourly 1 https://wordpress.org/?v=5.9.3 https://fcacleveland.org/wp-content/uploads/2021/10/icon-4-120x120.png Essay typer – FCA Cleveland http://fcacleveland.org/ 32 32 Alkaline Phosphatase Assay Kits Market Outlook 2022 and Growth by Top Key Players – MilliporeSigma, Abcam, Siemens, Thermo Fisher Scientific https://fcacleveland.org/alkaline-phosphatase-assay-kits-market-outlook-2022-and-growth-by-top-key-players-milliporesigma-abcam-siemens-thermo-fisher-scientific/ Tue, 28 Jun 2022 14:22:33 +0000 https://fcacleveland.org/alkaline-phosphatase-assay-kits-market-outlook-2022-and-growth-by-top-key-players-milliporesigma-abcam-siemens-thermo-fisher-scientific/ Alkaline Phosphatase Assay Kit Market A study by “Verified Market Reports” provides details on market dynamics affecting the Alkaline Phosphatase Assay Kits market, market scope, market segmentation and overlays on major market players, highlighting the landscape favorable competition and prevailing trends over the years. This Alkaline Phosphatase Assay Kits Market report provides details about recent […]]]>

Alkaline Phosphatase Assay Kit Market A study by “Verified Market Reports” provides details on market dynamics affecting the Alkaline Phosphatase Assay Kits market, market scope, market segmentation and overlays on major market players, highlighting the landscape favorable competition and prevailing trends over the years.

This Alkaline Phosphatase Assay Kits Market report provides details about recent new developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, strategic analysis of market growth, market size, category market growth, application and domain niches, product approvals, product launches, geographic expansions, technological innovations in the market. For more insights on Alkaline Phosphatase Assay Kits Market Data Bridge Market Research, please contact us for Analyst Briefing,

Get a sample copy (including full TOC, charts and tables) of this report @ https://www.verifiedmarketreports.com/download-sample/?rid=53281

The analysis and estimations made through the outstanding Alkaline Phosphatase Assay Kits report help to get an idea about the product launches, future products, joint ventures, marketing strategy, developments, mergers and acquisitions and their effects on sales, marketing, promotions, revenue value, import. , export and CAGR. With the latest and up-to-date market information mentioned in the report, companies can think about how to improve their marketing, promotion and sales strategies. Business reporting helps determine and optimize each stage of the business process lifecycle, which includes engagement, acquisition, retention, and monetization. Alkaline Phosphatase Assay Kits Market Research Report

Leading players in the Alkaline Phosphatase Assay Kit Market are:

  • MilliporeSigma
  • Abcam
  • Siemens
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Bio-Techne
  • GeneTex
  • Abnova
  • Bioassay systems
  • Randox Laboratories
  • MilliporeSigma

Global Alkaline Phosphatase Assay Kits Market Segmentation:

Global Alkaline Phosphatase Assay Kits Market Segment By Type:

  • Up to 100 pieces
  • 101-500 pieces
  • Above 500pcs

Global Alkaline Phosphatase Assay Kits Market Segment By Application:

  • Health care
  • Food and drinks
  • Others

Get an exclusive discount on this Premium report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=53281


Scope of the Alkaline Phosphatase Assay Kits Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.


Regional Analysis of the Alkaline Phosphatase Assay Kits Market can be represented as follows:

This part of the report assesses key regional and country-level markets on the basis of market size by type and application, key players, and market forecast.

Based on geography, the global alkaline phosphatase assay kits market has been segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia


To get more insights on market analysis, browse the research report summary @
https://www.verifiedmarketreports.com/product/global-alkaline-phosphatase-assay-kits-market-2019-by-manufacturers-regions-type-and-application-forecast-to-2024/

Visualize the Anesthesia Delivery Systems Market using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Anesthesia Delivery Systems Market using VMI@ https://www.verifiedmarketresearch.com/vmintelligence/

Most Popular Reports

Global Alkaline Phosphatase Kits Market Size and Forecast

Global Alkaline Phosphatase Assay Kits Market Size and Forecast

Global Oral Clinical Nutrition Supplements Market Size and Forecast

Global Medical Dynamometers Market Size and Forecast

Global Whole Slide Imaging Systems Market Size and Forecast

Global actigraphy sensors and polysomnography devices market size and forecast

Global Normal Saline Market Size and Forecast

Global Baby Warmer Market Size and Forecast

Global Baby Heel Warmer Market Size and Forecast

Global Custom Antibodies Market Size and Forecast

About Us: Verified Market Reports

Verified Market Reports is a leading global research and advisory company serving over 5000 global clients. We provide advanced analytical research solutions while delivering information-enriched research studies.

We also provide insight into the strategic and growth analytics and data needed to achieve business goals and critical revenue decisions.

Our 250 analysts and SMEs offer a high level of expertise in data collection and governance using industry techniques to collect and analyze data on over 25,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

Our research spans a multitude of industries, including energy, technology, manufacturing and construction, chemicals and materials, food and beverage, and more. Having served many Fortune 2000 organizations, we bring a wealth of reliable experience that covers all kinds of research needs.

Contact us:

Mr. Edwyne Fernandes

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: sales@verifiedmarketreports.com

Website: – https://www.verifiedmarketreports.com/

]]>
Human Papillomavirus Testing Market 2022 Key Players, Demands, Trends and Forecast to 2030 – Instant Interview https://fcacleveland.org/human-papillomavirus-testing-market-2022-key-players-demands-trends-and-forecast-to-2030-instant-interview/ Sun, 26 Jun 2022 14:08:50 +0000 https://fcacleveland.org/human-papillomavirus-testing-market-2022-key-players-demands-trends-and-forecast-to-2030-instant-interview/ Global “Human Papillomavirus Testing Market“Reports 2022 presents a key study on the status of the Human Papillomavirus Testing manufacturer industry with the specific statistics, meaning, definition, SWOT analysis, expert opinion and recent developments across the world. The research report also covers market size, price, sales, revenue, market share, gross margin, growth rate and cost structure. […]]]>
Global “Human Papillomavirus Testing Market“Reports 2022 presents a key study on the status of the Human Papillomavirus Testing manufacturer industry with the specific statistics, meaning, definition, SWOT analysis, expert opinion and recent developments across the world. The research report also covers market size, price, sales, revenue, market share, gross margin, growth rate and cost structure. The report aims to give a additional sample of the latest scenario, the economic downturn and the impact of Covid-19 on the whole industry.

The Human Papillomavirus Testing market report will provide forecasts based on real numbers and factual data to help you decide your marketing plans. You will understand which are the top profit sectors from the overview presented in the report. You can then take advantage of these opportunities based on your developed strategies and strengthen yourself in the market. Information is collected from real-time sources such as customers, dealers, raw material suppliers, etc. For this reason, the gathered data is authentic and will provide comprehensive details about the Human Papillomavirus Testing market.

Human Papillomavirus Testing Market: Competitive Landscape

The Human Papillomavirus Testing Market report includes insights into product launches, sustainability, and outlook from key vendors including: (
Roche, Seegene Inc, Becton Dickinson and Company, Hologic Inc, Qiagen NV, Arbor Vita Corporation, Abbott Laboratories, Quest Diagnostics,
,
)

Click Here for Free Sample Report of Human Papillomavirus Testing Market Report @ https://healthcaremarketreports.com/sample-request/human-papillomavirus-testing-market/50316/?utm_source=Payal&utm_medium =SatPr

Human Papillomavirus Testing Market: Segmentation

Human Papillomavirus Testing market is split by Type and by Application for the period 2022-2030, the growth between segments provides accurate artefacts and forecasts for sales by Type and by Application in terms of Volume and valuable. This analysis can help you grow your business by targeting qualified niche markets.

By type:
Systems
Dosing kits
Services

By app:
Clinical Microbiologist
Diagnostic centers
Hospitals
Clinical

Human Papillomavirus Testing Market: Regional Analysis

The whole regional segmentation has been studied based on recent and future trends, and the market is forecast through the forecast period. The countries covered in the regional analysis of Global Human Papillomavirus Testing Market report are US, Canada & Mexico North America, Germany, France, UK, Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium and the rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, Korea South, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Saudi Arabia, United Arab Emirates, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) under the Middle East and Africa (MEA), and Argentina, Brazil and Rest of South America as part of South America.

Main points covered in the table of contents:

Market overview: It includes six sections, research scope, key manufacturers covered, market fragments by type, Human Papilloma Virus Testing market portions by application, study objectives, and years considered.

Market landscape: Here, the global Human Papillomavirus Testing market opposition is dissected, by value, revenue, transactions, and slice of the pie by organization, market rate, fierce circumstances Latest landscape and patterns, consolidation, development, obtaining and parts of the entire industry of large organizations.

Manufacturer Profiles: Here, key players of the global Human Papillomavirus Testing market are considered dependent on region of deals, key elements, net benefit, revenue, cost, and creation.

Market Status and Outlook by Region: In this segment, the report examines net benefit, transactions, revenue, creation, global industry share, CAGR and market size by region. Here, Global Human Papillomavirus Testing Market is thoroughly examined based on regions and countries like North America, Europe, China, India, Japan, and MEA.

Application or end user: This segment of the exploration study demonstrates how extraordinary sections of end customers/applications are added to the global Human Papillomavirus Testing market.

Market forecast: Production side : In this part of the report, the creators focused on the conjecture of creation and creation esteem, the gauge of the main manufacturers and the estimation of the creation and creation esteem by type .

Research results and conclusion: This is one of the last segments of the report where the findings of the investigators and the end of the exploratory study are given.

Buy Direct Human Papillomavirus Testing Market Research Report Now @ https://healthcaremarketreports.com/purchase/human-papillomavirus-testing-market/50316/;utm_source=Payal&utm_medium=SatPr

Answers to key questions in the report:

  • What will be the pace of development of the Human Papillomavirus Testing market?
  • What are the key factors driving the Global Human Papillomavirus Testing market?
  • Who are the main manufacturers on the market?
  • What are the openings, dangers and contours of the market?
  • What are sales volume, revenue, and price analysis of top manufacturers of Human Papillomavirus Testing market?
  • Who are the distributors, traders and dealers of Human Papillomavirus Testing Market?
  • What are the Human Papillomavirus Testing market opportunities and threats faced by the vendors in the global Human Papillomavirus Testing industries?
  • What are Transactions, Revenue, and Value Reviews by Market Types and Uses?
  • What are reviews of transactions, revenue and value by business areas?

About Us

The healthcare industry is surely facing disruption, with global economies placing great importance on individual health. In this scenario, we expect our customers to get deep insights to propel their innovations in the right direction. We have closely followed the changes and modifications that occur in the field of health. According to our understanding, these alterations are active and unexampled.

Contact us

Healthcare Market Reports
99 Wall Street 2124 New York, NY 10005
E-mail: [email protected]
Our social networks: Facebook | LinkedIn | Twitter

]]>
With a CAGR of 6.7%, the immune repertoire sequencing market will hit https://fcacleveland.org/with-a-cagr-of-6-7-the-immune-repertoire-sequencing-market-will-hit/ Fri, 24 Jun 2022 13:05:00 +0000 https://fcacleveland.org/with-a-cagr-of-6-7-the-immune-repertoire-sequencing-market-will-hit/ Brooklyn, New York, June 24, 2022 (GLOBE NEWSWIRE) — Reports and Insights has just added a report titled “Immune Repertoire Sequencing Market: Analysis of opportunities and future assessment 2022-2030in its database of market research reports which offers its readers a detailed and in-depth analysis of new growth opportunities, trends and growth drivers closely related to […]]]>

Brooklyn, New York, June 24, 2022 (GLOBE NEWSWIRE) — Reports and Insights has just added a report titled “Immune Repertoire Sequencing Market: Analysis of opportunities and future assessment 2022-2030in its database of market research reports which offers its readers a detailed and in-depth analysis of new growth opportunities, trends and growth drivers closely related to market growth. The report further provides crucial insights regarding the impacts of COVID-19 on the Immune Repertoire Sequencing market along with the Compound Growth Rate (CAGR) of the market for an anticipated period between 2022 and 2030. According to research by Reports and Insights, the immune system repertoire sequencing market is estimated to reach a value of US$111.0 million by the end of 2022 and should reach to a worth US$186.9 million by 2030 with a significant CAGR of 6.7%. The report also includes an assessment of the market using various analytical tools, such as Porter’s Five Forces analysis and PESTEL analysis. These tools also offer in-depth analysis of micro and macro-environmental factors related to market growth over the projected period.

Get a sample full PDF copy of the report with table of contents: https://reportsandinsights.com/sample-request/4123

Introduction to immune repertoire sequencing

Immune repertoire sequencing has helped profile antigen-specific information in lymphocytes and has been shown to be essential in understanding the body’s mechanism of self-defense against foreign agents. Importantly, immune repertoire sequencing has proven to be an extremely useful tool for quantifying the configuration of B or T cell antigen receptor repertoires in basic research, such as immune repertoire development, vaccination, and lymphocyte lineage monitoring, as well as in several different clinical settings, such as monitoring hematopoietic stem cell transplant recovery, monitoring minimal residual disease (MRD), and prognosis of cancer patients. That said, early IR-seq experiments observed high PCR and sequencing errors that limited their ability to perform foolproof quantification of repertoire diversity and abundance.

Key insights from market research

  • The immune repertoire sequencing market is expected to reach a value of US$111.0M by the end of 2022 and is expected to reach a value of US$186.9M by 2030 with a significant CAGR of 6.7%
  • The test kits product segment in the immune repertoire sequencing market is expected to create an additional opportunity of US$25.6 million during the forecast period
  • In 2022, the cancer immunotherapy applications segment accounted for the largest market share and is expected to grow at 7.9% CAGR during the forecast period.
  • In 2022, the end-user segment of diagnostic laboratories accounted for the largest market share
  • Asia-Pacific is expected to remain the leading region in the global market and is expected to remain the fastest growing region
  • U.S. Immune Repertoire Sequencing Market Expected to Grow 1.8x during the forecast period

See the latest updates and developments in the Global Immune Repertoire Sequencing Market – https://reportsandinsights.com/pressrelease/immune-repertoire-sequencing-market

Immune Repertoire Sequencing Market Dynamics

Booming use of IR-seq in cancer immunotherapy

Cancer, being the leading cause of death globally, recently accounted for around 10 million deaths in 2020, or almost one in six deaths. Cancer usually arises from the transfiguration of normal cells into tumor cells in a multilevel process that usually develops from a precancerous lesion to a malignant tumor. Moreover, cancer treatment is again and again steeped in complexities. The disease’s unconstrained and pernicious cell growth is largely the result of erratic mutations in the body. Moreover, mutations persist as the disease progresses, producing heterogeneous tumors in which some tumor cells are likely to be unaffected by the treatment regimen. At the same time, the diversity of the immune repertoire is a robust indicator of disease status and response. In other words, sequencing of the immune repertoire can be seen as a robust instrument for assessing the immune repertoire, as it has the potential to qualitatively and quantitatively measure the diversity of the immune system. There are numerous cases in the literature in which the diversity of the immune repertoire has been linked to the presence or development of disease in cancer.

Recently, researchers from the Chinese Academy of Medical Sciences demonstrated that TCR-gamma CDR3 diversity is significantly reduced in patients with lung cancer. Similarly, patients with renal cell cancer show reduced repertoire diversity compared to normal controls. In another case, the collation of immune repertoires from pediatric and adult patients with acute myeloid leukemia revealed that clonal expansion of B and T cells occurs in diseased patients. Collectively, these results suggest that the representation of the immune repertoire has the ability to offer a robust diagnostic tool in the analysis of cancer. Immune cell repertoires can be assessed in certain cancers to better understand how the immune system changes during progression or remission. Finally, these representations are likely to even help suggest to clinicians the best treatment alternatives.

View report details before purchase – https://reportsandinsights.com/report/immune-repertoire-sequencing-market

Immune Repertoire Sequencing Market Segmentation

The global immune repertoire sequencing market is segmented on the basis of product, topic type, application, end-user and region

By product

Dosing kits

TCR Kits

BCR kits

Software

TCR Analysis Solutions

BCR Analysis Solutions

TCR and BCR analysis solutions

Instrument

FR

PCR

Services

Sequencing services

Data Analysis Services

Pre-sequencing services

By subject type

Human

Mouse

By request

Drug retrieval based on pharmacogenomics

Next Generation Sequencing

Polymerase chain reaction

Others

Discovery of biomarkers

Autoimmune diseases

Cancer immunotherapy

Infectious Disease Research

Asthma and Allergy Research

Vaccine development

Identification of immunodeficiency

Others

Per end user

Diagnostic laboratories

Pharmaceutical and biotechnology companies

Research institutes

Others

By region

North America

Latin America

Asia Pacific

Europe

Middle East

Africa

Immune Repertoire Sequencing Market Key Players

Some of the Major Participating Players in the Global Immune Repertoire Sequencing Market are:

Illumina, Inc.

Pacific Biosciences of California, Inc.

Agilent Technologies, Inc.

Oxford Nanopore Technologies, Ltd.

QIAGEN AG

Thermo Fisher Scientific

F. Hoffmann-La Roche SA

BGI

Takara Bio, Inc.

JUNO THERAPEUTIC

ADAPTIVE BIOTECHNOLOGIES

ARCHERDX, INC.

DIRECTORY, INC.

CD Genomics

To view top players, segmentation and other statistics of Immune repertoire sequencing Industry, get a sample report: @ https://reportsandinsights.com/sample-request/4123

About reports and insights:

Reports and Insights is a leading market research company that offers group and consulting research worldwide. At Reports and Insights, we adhere to client needs and reflect regularly to bring out more valuable and real results for our clients. We are equipped with a strategically strengthened group of researchers and analysts who redefine and stabilize trade polarity in different categorical dimensions of the market.

        
]]>
Vaccine efficacy in adults in a respiratory syncytial virus challenge study https://fcacleveland.org/vaccine-efficacy-in-adults-in-a-respiratory-syncytial-virus-challenge-study/ Wed, 22 Jun 2022 21:07:08 +0000 https://fcacleveland.org/vaccine-efficacy-in-adults-in-a-respiratory-syncytial-virus-challenge-study/ Summary Background Although human respiratory syncytial virus (RSV) is an important cause of illness and death in the elderly, no RSV vaccine has been licensed. Methods Download a PDF of the research summary. In a phase 2a study, we randomly assigned healthy adults (aged 18-50 years), in a 1:1 ratio, to receive a single intramuscular […]]]>

Summary

Background

Although human respiratory syncytial virus (RSV) is an important cause of illness and death in the elderly, no RSV vaccine has been licensed.

Methods

Download a PDF of the research summary.

In a phase 2a study, we randomly assigned healthy adults (aged 18-50 years), in a 1:1 ratio, to receive a single intramuscular injection of bivalent prefusion vaccine F (RSVpreF) or placebo . Approximately 28 days after injection, participants were inoculated intranasally with RSV A Memphis 37b challenge virus and observed for 12 days. The protocol-prespecified primary endpoints were: reverse transcriptase – quantitative polymerase chain reaction (RT-qPCR) – detectable RSV infection confirmed on at least 2 consecutive days with at least one clinical symptom of any which grade of two categories or at least one grade 2 symptom of any category, total symptom score from day 1 at discharge, and area under the curve (AUC) of RSV viral load in samples nasal lavage measured using RT-qPCR from day 2 after challenge to unload. Additionally, we assessed immunogenicity and safety.

Results

Once participants were inoculated with the challenge virus, a vaccine efficacy of 86.7% (95% CI, 53.8 to 96.5) was observed for symptomatic RSV infection confirmed by any RNA detectable virus for at least 2 consecutive days. The median RSV viral load AUC (hours × logten copies per milliliter) measured by the RT-qPCR test was 0.0 (interquartile range, 0.0 to 19.0) in the vaccinated group and 96.7 (interquartile range, 0.0 to 675.3) in the placebo group. The geometric mean factor increase from baseline in RSV A neutralizing titers at 28 days post-injection was 20.5 (95% CI, 16.6 to 25.3) in the vaccinated group and 1. 1 (95% CI, 0.9 to 1.3) in the placebo group. More local pain at the injection site was noted in the vaccinated group than in the placebo group. No serious adverse events were observed in either group.

conclusion

The RSVpreF vaccine was effective against symptomatic RSV infection and virus shedding. No obvious security issues were identified. These results support further evaluation of the RSVpreF vaccine in a Phase 3 efficacy study. (Funded by Pfizer; EudraCT number, 2020-003887-21; ClinicalTrials.gov number, NCT04785612.)

Digital object thumbnailQUICK SUMMARY OF THE VIDEO
Respiratory Syncytial Virus Vaccine Study
01:57

]]>
The Global B-Hydroxybutyrate (Ketone Bodies) Assay Kits Market will be driven by growing demand for diagnostic center products during the forecast period 2022-2027 https://fcacleveland.org/the-global-b-hydroxybutyrate-ketone-bodies-assay-kits-market-will-be-driven-by-growing-demand-for-diagnostic-center-products-during-the-forecast-period-2022-2027/ Mon, 20 Jun 2022 17:58:17 +0000 https://fcacleveland.org/the-global-b-hydroxybutyrate-ketone-bodies-assay-kits-market-will-be-driven-by-growing-demand-for-diagnostic-center-products-during-the-forecast-period-2022-2027/ Expert Market Research’s new report titled “Global B-Hydroxybutyrate (Ketone Body) Assay Kits Market Report and Forecast 2022-2027”, provides an in-depth analysis of the global B-Hydroxybutyrate (Ketone Body) Assay Kits market, assessing the market based on its segments such as test types, applications, end-uses, and major regions. The report tracks the latest industry trends and studies […]]]>

Expert Market Research’s new report titled “Global B-Hydroxybutyrate (Ketone Body) Assay Kits Market Report and Forecast 2022-2027”, provides an in-depth analysis of the global B-Hydroxybutyrate (Ketone Body) Assay Kits market, assessing the market based on its segments such as test types, applications, end-uses, and major regions. The report tracks the latest industry trends and studies their impact on the overall market. It also assesses market dynamics, covering key demand and price indicators, as well as market analysis based on SWOT and Porter’s Five Forces models.

Get a free sample report with table of contents: https://bit.ly/3HdA9yM

Key highlights of the report include:

Market Overview (2017-2027)

  • Forecast CAGR (2022-2027): 90%

Growing demand for B-Hydroxybutyrate (ketone body) assay kits from hospitals and diagnostic centers, owing to increasing cases of diabetic ketoacidosis, is driving the growth of the market. In addition to this, the increasing risk of hypoglycemia and hyperglycemia due to sedentary lifestyles led by the young population is expected to contribute to the growth of the market in the coming years. Moreover, the increasing awareness of the population about healthcare coupled with the rapid development of diagnostic centers is expected to boost the market during the forecast period. Geographically, North America accounts for a large share of the market due to rising healthcare expenditures and growing geriatric population in countries like the United States and Canada.

Industry definition and major segments

B-Hydroxybutyrate (Ketone Bodies) Assay Kits are defined as types of diagnostic kits used to measure levels of B-Hydroxybutyrate in plasma/serum. The operating principle of these kits is based on the cyclic reaction in which NAD+ is reduced to NADH. Moreover, these B-Hydroxybutyrate (ketone body) assay kits are reliable, accurate and provide accurate diagnosis of various health related issues.

Read the full report with table of contents: https://bit.ly/3NKKwN9

On the basis of Test Type, the market can be split into:

  • Fluorometric assay
  • Colorimetric dosage

On the basis of applications, the market has been categorized into:

  • Diabetes
  • Salicylate poisoning
  • Childhood hypoglycemia
  • Inborn errors of metabolism
  • Others

The major end-uses included in the market report are as follows:

  • Hospitals and Clinics
  • Ambulatory surgery centers
  • Pathology laboratories
  • Diagnostic centers
  • Others

Regional markets for B-hydroxybutyrate (ketone body) assay kits include:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Market trends

Major trends in the global B-Hydroxybutyrate (Ketone Bodies) Assay Kits market include the advancements in the healthcare industry, particularly in emerging economies. Favorable government policies and initiatives aimed at enhancing the overall health of the people are expected to invigorate the market during the forecast period. The increasing prevalence of diabetes and the risk of hypoglycemia, hyperglycemia and diabetic ketoacidosis are expected to increase the demand for these kits for timely testing. Additionally, growing research and development activities by major market players to reduce the cost of B-hydroxybutyrate (ketone body) assay kits at the point of care is expected to help the market in the coming years.

Main market players

The major market players are Abcam plc., Cell biolabs, Inc., BioAssay Systems, and AAT Bioquest, Inc., among others. The report covers market shares, capacities, plant rotations, expansions, investments, and mergers and acquisitions, among other latest developments of these market players.

About Us:

Expert Market Research is a leading business intelligence firm, providing custom and syndicated market reports and advisory services to our clients. We serve a wide clientele ranging from Fortune 1000 companies to small and medium-sized businesses. Our reports cover over 100 industries in established and emerging markets researched by our trained analysts who track the latest economic, demographic, business and market data globally.

At Expert Market Research, we tailor our approach based on the needs and preferences of our clients, providing them with valuable, actionable and up-to-date market insights, helping them realize their optimal growth potential. We offer market intelligence across a range of verticals including Pharmaceuticals, Food & Beverage, Technology, Retail, Chemicals & Materials, Energy & Mining, Packaging and agriculture.

Media Contact

Company Name: Claight Company
Contact Person:- Shira Ellis, Business Consultant
Email: sales@expertmarketresearch.com
Toll Free: USA +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: https://www.expertmarketresearch.com

Read more reports:

Quantum Computing Market: https://www.digitaljournal.com/pr/global-quantum-computing-market-to-be-drive-by-growing-end-use-sectors-in-the-forecast-period -of- 2021-2026-2

High Power LED Market: https://www.digitaljournal.com/pr/global-high-power-led-market-to-be-drive-by-increasing-use-of-energy-efficient-products-in- the -forecast-period-2021-2026

Irritable Bowel Syndrome Treatment Market: https://www.digitaljournal.com/pr/global-irritable-bowel-syndrome-treatment-market-to-be-drive-by-increasing-prevalence-of-target-diseases -in-the-forecast-period-2021-2026

Philippines LED Lighting Market: https://www.digitaljournal.com/pr/philippines-led-lighting-market-to-be-drive-by-demand-from-increasing-environmental-consciousness-in-the -forecast-period-from-2021-2026

North America Online Food Delivery Market: https://www.digitaljournal.com/pr/north-america-online-food-delivery-market-to-be-drive-by-significant-urban-population -busy-lifestyles-and -lack-of-domestic-help-over-the-forecast-period-2021-2026

Also, Check Procurement Intelligence which provides you with infallible research solutions.

* At Expert Market Research, we always strive to give you the latest information. The figures in the article are only indicative and may differ from the actual report.

]]>
Lateral Flow Testing Market Size 2029 https://fcacleveland.org/lateral-flow-testing-market-size-2029/ Sat, 18 Jun 2022 16:41:08 +0000 https://fcacleveland.org/lateral-flow-testing-market-size-2029/ New Jersey, United States – The Lateral Flow Analysis Market research report examines the market in detail over the anticipated period. The research is divided into sections, each of which includes analysis of market trends and changes. Drivers, limitations, opportunities, and barriers, as well as the impact of numerous aspects on the industry, are all […]]]>

New Jersey, United States – The Lateral Flow Analysis Market research report examines the market in detail over the anticipated period. The research is divided into sections, each of which includes analysis of market trends and changes. Drivers, limitations, opportunities, and barriers, as well as the impact of numerous aspects on the industry, are all variables of market dynamics.

The report provides participants with essential information as well as specific recommendations for gaining a competitive advantage in the global business world. It studies how different players compete in the global market and shows how they compete differently. The market size for the Lateral Flow Testing market is calculated using a projected period included in the research study. Current market status and trends, along with business growth drivers, industry share, sales volume, interesting BI dashboards, and market forces are all explored.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=23250

Key Players Mentioned in the Lateral Flow Testing Market Research Report:

Abbott Laboratories (US), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (US), Siemens AG (Germany), Becton, Dickinson and Company (US), bioMérieux SA (France), Bio-Rad Laboratories, Inc (USA), Thermo Fisher Scientific Inc. (USA), QIAGEN NV (Netherlands), PerkinElmer, Inc. (USA)

Our analysts performed a qualitative and quantitative analysis of the microeconomic and macroeconomic components of the Lateral Flow Testing market. This study will also help to understand changes in industrial supply chain, manufacturing processes and costs, sales scenarios and market dynamics of Lateral Flow Analyzer Market.

This analysis highlights significant mergers and acquisitions, business expansion, differences in goods or services, market structure, competitive conditions in the Lateral Flow Testing market and market size by the participant.

Global Lateral Flow Analysis Market Segmentation:

Lateral Flow Analytics Market, By Type

• Lateral stream readers
• Kits and reagents

Lateral Flow Analytics Market, By Technique

• Competitive trial
• Sandwich test
• Multiplex detection test

Lateral Flow Analytics Market, By Application

• Veterinary diagnosis
• Clinical/point-of-care testing
• Drug development and quality testing

Lateral Flow Analytics Market, By End User

• Home Care
• Diagnostic laboratories
• Hospitals and clinics
• Pharmaceutical and biotechnology companies

Inquire for a discount on this Premium Report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=23250

Scope of the Lateral Flow Testing Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

Answers to key questions in the report:

1. Who are the top five players in the Lateral Flow Analysis market?

2. How will the lateral flow test market develop over the next five years?

3. Which product and which application will capture the lion’s share of the lateral flow dosing market?

4. What are the drivers and restraints of the Lateral Flow Testing Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Lateral Flow Analyzer market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/lateral-flow-assay-market/

Visualize the Lateral Flow Testing Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a comprehensive overview and global competitive landscape with respect to region, country, and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Lateral Flow Analytics Market Using VMI@ https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768

E-mail: sales@verifiedmarketresearch.com

Website:- https://www.verifiedmarketresearch.com/

]]>
Caspase Assay Kits Market Expected to Grow at a High CAGR and Reach USD Million by 2030 – Indian Defense News https://fcacleveland.org/caspase-assay-kits-market-expected-to-grow-at-a-high-cagr-and-reach-usd-million-by-2030-indian-defense-news/ Tue, 14 Jun 2022 18:20:47 +0000 https://fcacleveland.org/caspase-assay-kits-market-expected-to-grow-at-a-high-cagr-and-reach-usd-million-by-2030-indian-defense-news/ The caspase assay kits market report makes available current and upcoming technical and financial details of the industry. This is one of the most comprehensive and significant additions to the Prudent Markets market research archive. It offers detailed research and analysis of key aspects of the global Caspase Assay Kits market. This report explores […]]]>

The caspase assay kits market report makes available current and upcoming technical and financial details of the industry. This is one of the most comprehensive and significant additions to the Prudent Markets market research archive. It offers detailed research and analysis of key aspects of the global Caspase Assay Kits market. This report explores all the key factors affecting the growth of the global Caspase Assay Kits market, including demand-supply scenario, price structure, profit margins, production and value chain analysis.

The report ends with the profiles of the main players of the Caspase Assay Kits market: AnaSpec, Cell Signaling Technology, Takara Bio, Abcam, BioVision, Enzo Life Sciences, GeneTex, PromoCell

Find out who you really compete with in the market, get a free sample PDF report now! https://www.prudentmarkets.com/sample-request/125447/

Type segmentation: Fluorometric type, 3/7 assay kit

Industry Segmentation: Laboratories, Hospitals

caspase assay kits market

Prudent Markets offers attractive discounts that suit your needs. Customization of reports according to your needs is also offered. Get in touch with our sales team, who will guarantee you a report adapted to your needs.

Speak to our analyst for a discussion on the results above and request a discount on the report @ https://www.prudentmarkets.com/discount-request/125447/

The report covers the competitive analysis of the market. As the demand is determined by a buyer’s ability to pay and the development rate of the items, the report shows the important regions which will guide the growth. This section exclusively shares an overview of the budget reports of the major league members of the market, helping key players and new entrants to understand the investment potential in the global Caspase Assay Kits market. It can be best utilized by traditional and new industry players for complete market know-how.

Regional Analysis For Caspase Assay Kits Market:
North America (US and Canada)
Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
Latin America (Brazil, Mexico and rest of Latin America)
Middle East and Africa (South Africa, GCC and Rest of Middle East and Africa)

Strategic Points Covered in Table of Content of Global Caspase Assay Kits Market:

Chapter 1: Introduction, Market Driving Product Study Objective and Research Scope of the Caspase Assay Kits Market
Chapter 2: Exclusive Summary – the basic information of the Caspase Assay Kits Market.
Chapter 3: Viewing Market Dynamics – Drivers, Trends and Caspase Assay Kits Challenges and Opportunities
Chapter 4: Introducing Caspase Assay Kits Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL Analysis, Market Entropy, Patent Analysis/ brands.
Chapter 5: View by type, end user and region/country
Chapter 6: Evaluating the leading manufacturers of the Caspase Assay Kits Market which includes its Competitive Landscape, Peer Group Analysis, BCG Matrix and Company Profile
Chapter 7: To assess the market by segments, by countries and by manufacturers/company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Display of appendix, methodology and data source

Questions? Do not hesitate to inquire here. Well get yourself on the right track @ https://www.prudentmarkets.com/enquiry-request/125447/

Free customization based on customer requirements when buying it now:
1- Free country-level breakdown of 5 countries you are interested in.
2- Competitive segment revenue distribution by market players.

Report customization:
This report can be customized to meet customer requirements. Please connect with our sales team ([email protected]), which will ensure that you get a report that suits your needs. You can also get in touch with our leaders on +91 83560 50278 || USA/Canada (toll free): 1800-601-6071 to share your research needs.

Prepare to recognize the pros and cons of the regulatory framework, local reforms and their effects on the industry. Find out how smart grid leaders are staying ahead with our latest survey analysis.

In conclusion, the Caspase Assay Kits Market report is a veritable source of access to research data that is expected to grow your business exponentially. The report provides information such as economic scenarios, benefits, limitations, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also included in the report.




]]>
Micronucleus (COVID-19) Testing Kits Market to Witness Stunning Growth Forecast 2022-2028 | BD Biosciences, Litron Laboratories, Thermo Fisher Scientific, acCELLerate GmbH, Xenometrix, etc. https://fcacleveland.org/micronucleus-covid-19-testing-kits-market-to-witness-stunning-growth-forecast-2022-2028-bd-biosciences-litron-laboratories-thermo-fisher-scientific-accellerate-gmbh-xenometrix-etc/ Mon, 13 Jun 2022 01:24:46 +0000 https://fcacleveland.org/micronucleus-covid-19-testing-kits-market-to-witness-stunning-growth-forecast-2022-2028-bd-biosciences-litron-laboratories-thermo-fisher-scientific-accellerate-gmbh-xenometrix-etc/ Micronucleus-Test-Kits-market Micronucleus Test Kits Market Report Coverage: Key Growth Drivers and Challenges, Regional Segmentation and Outlook, Key Industry Trends and Opportunities, Competitive Analysis, COVID-19[feminine] Impact analysis and projected recovery, and market sizing and forecasting. Latest research launched on Global Micronucleus Test Kits Market, it provides a detailed analysis with presentable graphs, charts and tables. […]]]>

Micronucleus-Test-Kits-market

Micronucleus Test Kits Market Report Coverage: Key Growth Drivers and Challenges, Regional Segmentation and Outlook, Key Industry Trends and Opportunities, Competitive Analysis, COVID-19[feminine] Impact analysis and projected recovery, and market sizing and forecasting.

Latest research launched on Global Micronucleus Test Kits Market, it provides a detailed analysis with presentable graphs, charts and tables. This report covers an in-depth study of the Micronucleus Testing Kits Market size, growth and share, trends, consumption, segments, application and forecast 2028. Through qualitative analysis and quantitative, we help you do a thorough and comprehensive research on the global micronucleus test. Kit market. This report has been prepared by experienced and knowledgeable market analysts and researchers. Each section of the research study is specially prepared to explore key aspects of the global Micronucleus Test Kits market. Buyers of the report will have access to accurate information PESTLE, SWOT and other types of analysis on the global Micronucleus Test Kits Market. In addition, it offers very precise estimates on the CAGR, market share and market size of key regions and countries.

Major Key Players profiled in the report include: BD Biosciences, Litron Laboratories, Thermo Fisher Scientific, acCELLerate GmbH, Xenometrix, IPHASE and more…

Download a free sample PDF including COVID-19[FEMININE Analyse d’impact, table des matières complète, tableaux et [email protected]
https://www.marketinforeports.com/Market-Reports/Request-Sample/387378

Don’t miss the business opportunities in the Micronucleus Test Kits Market. Talk to our analyst and get key industry insights that will help your business grow when you create sample PDF reports.

Segmental analysis:
The report categorized the global micronucleus test kits market into segments comprising product type and application. Each segment is assessed based on its share and growth rate. Additionally, analysts have studied potential regions that could prove rewarding for microkernel test kit makers in the coming years. The regional analysis includes reliable predictions about value and volume, helping market players to gain in-depth insights into the overall Micronucleus Test Kits industry.

Market Segment by Type, covers:
In vitro micronucleus assay
In vivo micronucleus assay

Market Segment by Applications can be split into:
Mouse/Rat Micronucleus Test Kit
Canine Micronucleus Test Kit
Non-human primate micronucleus test kit

Share your budget and get an exclusive discount @
https://www.marketinforeports.com/Market-Reports/Request_discount/387378

The report authors have analyzed the developing and developed regions considered for research and analysis of the global Micronucleus Test Kits Market. The regional analysis section of the report provides in-depth research study on different regional and country-level Microkernel Testing Kits industries to help players plan effective expansion strategies.

Regions Covered in Global Micronucleus Test Kits Market:
The Middle East and Africa (GCC countries and Egypt)
North America (United States, Mexico and Canada)
South America (Brazil, etc)
Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
Asia Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia and Australia)

Years considered to estimate the market size:
Historical year: 2015-2021
Year of reference : 2021
Estimated year: 2022
Forecast year: 2022-2028

Detailed TOC of Micronucleus Test Kits Market Report 2022-2028:
Chapter 1: Micronucleus Test Kits Market Overview
Chapter 2: Economic impact on the industry
chapter 3: Market Competition by Manufacturers
Chapter 4: Production, revenue (value) by region
Chapter 5: Supply (Production), Consumption, Export, Import by Regions
Chapter 6: Production, revenue (value), price trend by type
Chapter 7: Market analysis by application
Chapter 8: Analysis of manufacturing costs
Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10: Marketing Strategy Analysis, Distributors/Traders
Chapter 11: Analysis of market effect factors
Chapter 12: Microkernel Test Kits Market Forecast
Continued……

To learn more about the report, visit @ https://www.marketinforeports.com/Market-Reports/387378/Micronucleus-Test-Kits-market

What market dynamics does this report cover?
The report shares key information on:

  • Current market size
  • Market forecasts
  • Market opportunities
  • Main Drivers and Constraints
  • Regulatory scenario
  • Industry trend
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Price analysis
  • Competitive landscape

It helps companies make strategic decisions.

Does this report offer customization?
Personalization helps organizations better understand specific market segments and areas of interest. Therefore, Market Information Reports provides customized reporting information based on business needs for mission-critical calls.

Get Customization [email protected]:
https://www.marketinforeports.com/Market-Reports/Request-Customization/387378/Micronucleus-Test-Kits-market

Why Choose Market Intelligence Reports? :
Market Info Reports Research provides strategic market research reports, industry analysis, statistical surveys and forecast data on products and services, markets and companies. Our clientele includes a mix of global business leaders, government organizations, SMEs, individuals and start-ups, leading management consultancies, universities, and more. Our library of over 600,000 reports targets high-growth emerging markets in the United States, Europe Middle East, Africa, Asia-Pacific covering sectors like Computers, telecommunications, chemicals, semiconductors, healthcare, pharmaceuticals, energy and electricity, manufacturing, automotive and transport, food and beverages, etc.. This extensive collection of insightful reports helps clients stay ahead of time and the competition. We assist in business decision making on aspects such as market entry strategies, market size, market share analysis, sales and revenue, technology trends, competitive analysis, product portfolio and application analysis, etc.

Contact us:
Market Information Reports
17224 Rue S. Figueroa,
Gardena, California (CA) 90248, United States
Call: +1 915 229 3004 (WE)
+44 7452 242832 (UK)
Website: www.marketinforeports.com




]]>
Electronic nose detects SARS-CoV-2 from breath https://fcacleveland.org/electronic-nose-detects-sars-cov-2-from-breath/ Wed, 08 Jun 2022 23:46:00 +0000 https://fcacleveland.org/electronic-nose-detects-sars-cov-2-from-breath/ Early diagnosis of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the coronavirus disease 2019 (COVID-19) pandemic, is important to limit its transmission. In this context, a reliable point-of-care screening system is urgently needed. Some of the characteristics needed for mass testing of COVID-19 include short detection time, inexpensive procedure, […]]]>

Early diagnosis of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the coronavirus disease 2019 (COVID-19) pandemic, is important to limit its transmission. In this context, a reliable point-of-care screening system is urgently needed. Some of the characteristics needed for mass testing of COVID-19 include short detection time, inexpensive procedure, and simple sample collection method.

Study: Detection of COVID-19 from exhaled breath – Clinical studies. Image Credit: Danilina Olga / Shutterstock.com

Background

The reverse transcription-polymerase chain reaction (RT-PCR) test is the gold standard for detecting COVID-19. However, this technique cannot be used for rapid and mass testing, as RT-PCR requires trained personnel to take test samples from the infected person and perform this test.

Thus, the development of an exhaled breath analysis device for the rapid detection of COVID-19 could be extremely practical. This type of device could be very beneficial due to its simple sample collection method, non-invasive nature, reusability and ability to provide results in a short interval.

Interestingly, previous studies have reported an odor distinct from COVID-19 patients that was easily detected by dogs. The compound that was detected by the dog was then analyzed by gas chromatography-ion mobility spectrometry.

Breath samples can be used to detect SARS-CoV-2 infection by determining the presence of volatile organic compounds (VOCs) in the sample. The exhaled breath of a COVID-19 patient contains specific VOCs that arise due to altered metabolic reactions or changes in the microbiota of the lungs during infection.

Exhaled breath, which contains various gases including VOCs, can be acquired through an electronic nasal device. Unlike RT-PCR tests, an electronic nasal device can easily detect SARS-CoV-2 infection during its various stages of development.

Several studies have reported the development of nanoparticle gas sensors, carbon nanotube sensors, and metal oxide gas sensors for the selective detection of VOCs. Previous studies have also shown that exhaled breath analysis techniques can detect viruses, such as influenza and human rhinoviruses, through analysis of exhaled VOCs using an electronic nasal device.

There are several concerns regarding the detection of COVID-19 by an electrical nasal breath analyzer, such as the limited repeatability of detecting infections by this approach. Moreover, these devices cannot be applied in various environmental conditions for the collection and analysis of breath samples.

About the study

In a recent study under review in the journal Scientific Reports and published on the preprint server Research Square*, researchers discuss the development of an electronic nose device for VOC detection using commercial gas sensors, which require little power to operate at high temperatures. Here, researchers conducted clinical studies in the northern part of Poland to assess the effectiveness of the device.

In the current study, the scientists carried out the experimental studies in hospital wards dedicated to the treatment of patients infected with SARS-CoV-2 during the third wave of COVID-19 in Poland, which took place between March and July 2021. Breath samples were obtained from the university. Center for Maritime and Tropical Medicine, Poland, then analyzed by the new electronic nasal device.

A total of 56 breath samples, which consisted of 33 samples obtained from severely infected COVID-19 patients, 17 from healthy controls and six from ambient air, were used for the current study. All samples were taken in the morning after study participants had brushed their teeth but before breakfast. This measure was taken to reduce the sampling of contaminated breath.

Approximately 130 mL of breath sample was collected by a BioVOC™ breath sampler from all study participants breathing in the same hospital ward atmosphere.

Developed electronic nose analyzing the exhaled breath sample using the end-expiratory portion of the final wave, and (b) illustration of breath sample collection with the BioVOCTM.

Developed electronic nose analyzing the exhaled breath sample using the final tidal part of the final wave, and (b) illustration of breath sample collection with the BioVOCMT.

Study results

Breath samples obtained from COVID-19 patients showed higher moisture levels than controls. Notably, the electronic nose device used here provided a better detection rate of COVID-19 for the elderly group than for younger patients. In fact, the device provided detection accuracy as low as 80% in some younger patients.

The device described here could be used to assess the effectiveness of a particular medical treatment or for mass pre-screening. One of the challenges associated with this device is its limited accuracy when used outdoors; thus, future studies should focus on improving its accuracy and improving its resistance to fluctuating environmental factors.

Future research

Taken together, the results of the present study strongly suggest that the use of commercial gas sensors is favorable for the identification of VOCs in breath samples. Therefore, the device and methodology used in the present study could be practically applied for the detection of COVID-19.

In the future, further research is needed to determine why repeated calibration of the device should be performed during operation. In addition, a more efficient and faster procedure for cleaning the gas sensor is needed.

*Important Notice

Research Square publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be considered conclusive, guide clinical practice/health-related behaviors, or treated as established information.

]]>
DNA-guided approach to circulating tumor safely reduces the use of chemotherapy in colon cancer https://fcacleveland.org/dna-guided-approach-to-circulating-tumor-safely-reduces-the-use-of-chemotherapy-in-colon-cancer/ Sat, 04 Jun 2022 16:59:14 +0000 https://fcacleveland.org/dna-guided-approach-to-circulating-tumor-safely-reduces-the-use-of-chemotherapy-in-colon-cancer/ Source/Disclosures Published by: Source: TieJ, et al. Abstract LBA100. Presented at: ASCO Annual Meeting; June 3-7, 2022; Chicago. Disclosures: Conrad R Hilton Foundation, Eastern Health Research Foundation, John Templeton Foundation, Lustgarten Foundation, The Marcus Foundation, NIH, Sol Goldman Charitable Trust, and The Virginia and DK Ludwig Fund for Cancer Research supported the study. […]]]>


Source/Disclosures

Source:

TieJ, et al. Abstract LBA100. Presented at: ASCO Annual Meeting; June 3-7, 2022; Chicago.


Disclosures: Conrad R Hilton Foundation, Eastern Health Research Foundation, John Templeton Foundation, Lustgarten Foundation, The Marcus Foundation, NIH, Sol Goldman Charitable Trust, and The Virginia and DK Ludwig Fund for Cancer Research supported the study. Tie does not report any relevant financial information. Please see the summary for all relevant financial disclosures from the researchers. Montagut does not report any relevant financial information. Vidal does not report any relevant financial information.


We have not been able to process your request. Please try again later. If you continue to have this problem, please contact customerservice@slackinc.com.

CHICAGO — DNA analysis of circulating tumors has safely reduced the use of adjuvant chemotherapy without compromising recurrence-free survival in patients with stage II colon cancer, according to results from the phase 2 randomized trial DYNAMIC.

The results, presented at the ASCO annual meeting and published simultaneously in The New England Journal of Medicineshowed that patients with circulating tumor DNA (ctDNA) negative disease had a lower likelihood of benefiting from chemotherapy, while ctDNA-positive patients experienced a survival benefit from adjuvant chemotherapy .


DNA 1

Source: Adobe Stock.

Rationale and methods

“Most patients with stage II colon cancer are cured by their surgery to remove the bowel cancer, but about 20% will develop a recurrence in subsequent years,” Jeanne Tie, MD, MBChB, FRACP, lower gastrointestinal medical oncology and trial management at the Peter MacCallum Cancer Center in Australia, Healio told. “Treating all Stage II patients with chemotherapy will reduce the risk of recurrence by around 15%, but that means 20 patients need to be treated to benefit one patient.”

The goal of adjuvant chemotherapy is to eradicate micrometastases, she added.

Jeanne Tie, MD, MBChB, FRACP

Jeanne tie

“The challenge has been that these microscopic deposits of cancer cells are tiny and not visible during surgery or visible on X-ray images,” Tie said. “A ctDNA analysis can detect tiny amounts of DNA released by these invisible cells into the bloodstream, allowing us to identify patients who have micrometastases and who, therefore, should be offered chemotherapy. Conversely, when the blood test does not reveal ctDNA, the likelihood of micrometastases is very low and chemotherapy can be avoided without compromising the risk of recurrence.

The researchers sought to assess whether ctDNA-guided treatment could reduce the use of adjuvant chemotherapy without compromising the risk of recurrence in 455 patients with resected stage II colon cancer. They randomly assigned patients to either ctDNA-guided treatment (n=302) or physician-guided treatment (n=153).

The non-inferiority of the RFS rate at 2 years served as the primary endpoint, with the use of adjuvant chemotherapy as a secondary endpoint.

The median follow-up was 37 months.

Main findings

Overall, 15.3% of patients assigned to ctDNA-guided therapy received adjuvant chemotherapy compared to 27.9% of those assigned to physician-guided therapy (OR = 2.14; P = .002). The researchers noted the greatest difference in patients with T4 (OR = 6.22) or poorly differentiated tumors (OR = 6.31).

Among those who received adjuvant chemotherapy, oxaliplatin-based doublet was used more frequently than fluoropyrimidine alone among those in the ctDNA-guided treatment group compared to those who received physician-guided treatment (62 .2% versus 9.8%; P < .001).

The researchers also found that ctDNA-guided treatment was not inferior to standard management for RFS at 2 years (93.5% vs. 92.4%), an absolute difference of 1.1 points percentage (95% CI, -4.1 to 6.2). They reported 3-year RFS rates of 86.4% after using adjuvant chemotherapy in ctDNA-positive patients and, among ctDNA-negative patients, 92.5% without chemotherapy. adjuvant and 96.7% in a subgroup of patients at low clinical risk.

“We have shown that cDNA testing can differentiate patients with stage II colon cancer who need chemotherapy after surgery from those who have a very low risk of recurrence and can avoid treatment by safely,” Tie said. “Importantly, the use of chemotherapy is significantly reduced with the use of this ctDNA-based approach with no impact on the risk of recurrence.”

Look forward

“The ctDNA test has the potential to revolutionize the approach to chemotherapy in colon cancer patients – avoiding unnecessary chemotherapy treatments in the majority – and will accelerate the development of promising new treatment options,” said declared Tie. “We are currently conducting trials in stage III colon cancer and other types of cancer, such as pancreatic cancer and ovarian cancer.”

Several recommendations arise from this trial that may be useful when considering possible clinical implementation, Clara Montagut, MD, PhD, head of the gastrointestinal cancer unit and medical oncologist Joana Vidal, MD, both at Hospital del Mar in Barcelona, ​​Spain, wrote in an editorial accompanying the study published in The New England Journal of Medicine.

“The trial used a ctDNA test specifically designed for minimal residual disease applications with very high sensitivity, as well as serial blood samples for ctDNA analysis to reduce the risk of a false negative result. “, they wrote. “Logistically, prompt processing and short turnaround time for ctDNA results are essential to avoid delays in initiation of adjuvant chemotherapy. The present assay employed a tissue-based strategy in which ctDNA probes were customized based on specific mutations identified in tumor tissue. Although this strategy confers high sensitivity, tissue-independent strategies could also be valid while reducing the time to results.

New advances in technology will undoubtedly improve the performance of cDNA testing for minimal residual disease, including the incorporation of tumor-specific methylation profiles, they added.

References:

Montagut C and Vidal J. N Eng J Med. 2022;doi:10.1056/NEJMe2204625.
TieJ, et al. Abstract LBA100. Presented at: ASCO Annual Meeting; June 3-7, 2022;
Chicago.Tie J, et al. N Engl J Med. 2022;doi:10.1056/NEJMoa2200075.

For more information:

Jeanne tie, MD, MBChB, FRACP, can be contacted at tie.j@wehi.edu.au.

]]>